Dekel Pharmaceuticals

Compositions for Inflammatory Disorders

Health Tech & Life Sciences
Acquired (Inactive) by SciSparc on Oct 2014 - closed due to acquisition
Acquired Ramat Gan Founded 2008
LinkedIn
Total raised
Stage
Acquired
Founded
2008
Headcount
1-10
HQ
Ramat Gan
Sector
Health Tech & Life Sciences

About

Dekel Pharmaceuticals Ltd developed compositions and methods suitable for treatment of inflammatory disorders.

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is the primary focus of Dekel Pharmaceuticals' research and development?
Dekel Pharmaceuticals Ltd developed compositions and methods for the treatment of inflammatory disorders.
When was Dekel Pharmaceuticals founded?
Dekel Pharmaceuticals was founded in October 2008.
What is the current status of Dekel Pharmaceuticals?
Dekel Pharmaceuticals is currently inactive, having been acquired in October 2014.
Which company acquired Dekel Pharmaceuticals?
Dekel Pharmaceuticals was acquired by SciSparc in October 2014.
Where is Dekel Pharmaceuticals headquartered?
Dekel Pharmaceuticals is headquartered in Ramat Gan, Center District, Israel.
What sector does Dekel Pharmaceuticals operate in?
Dekel Pharmaceuticals operates in the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology and Drugs Discovery & Development.
What is the estimated employee count for Dekel Pharmaceuticals?
Dekel Pharmaceuticals had an estimated employee count of 1-10.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Tags

drug-discoveryinflammatory-diseases